+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Japanese Encephalitis Vaccines Market 2021-2025- Product Image

Global Japanese Encephalitis Vaccines Market 2021-2025

  • ID: 5300886
  • Report
  • February 2021
  • Region: Global, Japan
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.Â
  • Panacea Biotec Ltd
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Japanese Encephalitis Vaccines Market 2021-2025

The publisher has been monitoring the Japanese encephalitis vaccines market and it is poised to grow by $54.39 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. The report on Japanese encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the inclusion in national immunization plan and strategic alliances. In addition, inclusion in national immunization plan is anticipated to boost the growth of the market as well.

The Japanese encephalitis vaccines market analysis includes type segment and geographical landscapes.

The Japanese encephalitis vaccines market is segmented as below:

By Type
  • Inactivated vaccines
  • Recombinant vaccines
  • Live attenuated vaccines
By Geographical Landscapes
  • Asia
  • ROW
  • Europe
  • North America
This study identifies the growing number of awareness campaigns as one of the prime reasons driving the Japanese encephalitis vaccines market growth during the next few years.

Thereport on Japanese encephalitis vaccines market covers the following areas:
  • Japanese encephalitis vaccines market sizing
  • Japanese encephalitis vaccines market forecast
  • Japanese encephalitis vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Japanese encephalitis vaccines market vendors that include Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc. , Panacea Biotec Ltd, Sanofi, Shandong Hengye Biotechnology Co. Ltd., VA Bio+Tech Park, and Valneva SE. Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.Â
  • Panacea Biotec Ltd
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Inactivated vaccines - Market size and forecast 2020-2025
  • Recombinant vaccines - Market size and forecast 2020-2025
  • Live attenuated vaccines - Market size and forecast 2020-2025
  • Market opportunity by Type
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd
  • Sanofi
  • Shandong Hengye Biotechnology Co. Ltd.
  • VA Bio+Tech Park
  • Valneva SE
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Inactivated vaccines - Market size and forecast 2020-2025 ($ million)
  • Inactivated vaccines - Year-over-year growth 2020-2025 (%)
  • Recombinant vaccines - Market size and forecast 2020-2025 ($ million)
  • Recombinant vaccines - Year-over-year growth 2020-2025 (%)
  • Live attenuated vaccines - Market size and forecast 2020-2025 ($ million)
  • Live attenuated vaccines - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Adimmune Corp. - Overview
  • Adimmune Corp. - Business segments
  • Adimmune Corp. - Key offerings
  • Adimmune Corp. - Key customers
  • Adimmune Corp. - Segment focus
  • Bharat Biotech Ltd. - Overview
  • Bharat Biotech Ltd. - Product and service
  • Bharat Biotech Ltd. - Key offerings
  • Bharat Biotech Ltd. - Key customers
  • Bharat Biotech Ltd. - Segment focus
  • Biological E. Ltd. - Overview
  • Biological E. Ltd. - Product and service
  • Biological E. Ltd. - Key offerings
  • Biological E. Ltd. - Key customers
  • Biological E. Ltd. - Segment focus
  • KM Biologics Co. Ltd. - Overview
  • KM Biologics Co. Ltd. - Product and service
  • KM Biologics Co. Ltd. - Key offerings
  • KM Biologics Co. Ltd. - Key customers
  • KM Biologics Co. Ltd. - Segment focus
  • Medigen Inc. - Overview
  • Medigen Inc. - Product and service
  • Medigen Inc. - Key offerings
  • Medigen Inc. - Key customers
  • Medigen Inc. - Segment focus
  • Panacea Biotec Ltd - Overview
  • Panacea Biotec Ltd - Business segments
  • Panacea Biotec Ltd - Key offerings
  • Panacea Biotec Ltd - Key customers
  • Panacea Biotec Ltd - Segment focus
  • Sanofi - Overview
  • Sanofi - Business segments
  • Sanofi - Key offerings
  • Sanofi - Key customers
  • Sanofi - Segment focus
  • Shandong Hengye Biotechnology Co. Ltd. - Overview
  • Shandong Hengye Biotechnology Co. Ltd. - Product and service
  • Shandong Hengye Biotechnology Co. Ltd. - Key offerings
  • Shandong Hengye Biotechnology Co. Ltd. - Key customers
  • Shandong Hengye Biotechnology Co. Ltd. - Segment focus
  • VA Bio+Tech Park - Overview
  • VA Bio+Tech Park - Product and service
  • VA Bio+Tech Park - Key offerings
  • VA Bio+Tech Park - Key customers
  • VA Bio+Tech Park - Segment focus
  • Valneva SE - Overview
  • Valneva SE - Business segments
  • Valneva SE - Key offerings
  • Valneva SE - Key customers
  • Valneva SE - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.Â
  • Panacea Biotec Ltd
The publisher recognizes the following companies as the key players in the Global Japanese encephalitis vaccines market: Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc. , Panacea Biotec Ltd, Sanofi, Shandong Hengye Biotechnology Co. Ltd., VA Bio+Tech Park, and Valneva SE.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing number of awareness campaigns.'

According to the report, one of the major drivers for this market is the inclusion in national immunization plan.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.Â
  • Panacea Biotec Ltd
  • Sanofi
  • Shandong Hengye Biotechnology Co. Ltd.
  • VA Bio+Tech Park
  • Valneva SE
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll